IL17A and gastric cancer: In patients with gastric cancer at stage IV of the disease, multidirectional changes occur when studying proinflammatory cytokines: a decrease in TNF-α, IL-8, TNF-β, as well as an increase in IL-2, IFNγ, IL-17A, and IL-6.